Stilla is exhibiting at

World Clinical Biomarkers & CDx Summit

September 28-29 l Boston, MA

Returning in-person for the first time in three years, hear the latest insights, case studies and technologies enhancing your predictive biomarker discovery, to support next generation CDx development, informed clinical decisions, regulatory approval & a robust go-to market strategy for a breakthrough therapy.